The West Midlands Ambulance Service University NHS Foundation Trust Board of Directors met on Wednesday 28 October 2026 at Trust Headquarters, Millennium Point, Brierley Hill, with attendees also joining via Microsoft Teams.
The minutes of the meeting are available below and provide a record of the discussions, reports, decisions and resolutions made by the Board. Topics covered include operational performance, patient safety, hospital handover delays, financial performance, workforce matters and the Trust’s strategic priorities.
Present
- Prof I Cumming* (Chairman) – Non-Executive Director (Chairman)
- Mr A C Marsh* (CEO) – Chief Executive Officer
- Prof. A Hopkins (AH) – Non-Executive Director (Deputy Chair)
- Mrs S Banks* (SB) – Non-Executive Director
- Ms C Beechey* (CB) – Director of People
- Mr A Brown (AB) – Transformation & Patient Safety Director
- Mrs C Eyre* (CE) – Director of Nursing
- Mr N Hudson* (NH) – Chief Operation Officer
- Mr M Khan* (MK) – Non-Executive Director
- Mr V Khashu (VK) – Strategy & Engagement Director
- Mr M MacGregor (MM) – Communications Director
- Mr S Nat* (SN) – Non-Executive Director
- Mrs K Rutter* (KR) – Director of Finance
- Dr R Steyn* (RS) – Medical Director
* Denotes a voting member appointed pursuant to the Constitution of the West Midlands Ambulance Service NHS Foundation Trust.
In attendance
- Mr P. Higgins (PH) – Governance Director & Trust Secretary
- Mrs R Farrington (RF) – Staff Side Representative
- Ms K Freeman (KAF) – Private Secretary
- Ms C Tilley (CT) – HSJ
- Mr A Williams (AW) – Member of the Public
- Mr I Syme (IS) – Member of the Public
10/26/01 – Welcome, Apologies and Chairman’s Matters
The Chairman welcomed everyone to the meeting.
Apologies for absence received from Mrs Jasper and Mr Fessal.
10/26/02 – Declarations of Interest
None declared in relation to any matters on the agenda for this meeting.
10/26/03 – Minutes
The Board was requested to approve the minutes of the meeting of the Board of Directors held on 29 July 2026 as an accurate record.
Resolved:
- That the minutes of the meeting of the Board of Directors held on 29 July 2026 be approved as a correct record of that meeting.
10/26/04 – Questions from the Public
No questions received.
10/26/05 – Action Log and any Matters Arising not on the agenda for this meeting
05a – The Board Log
The Board Action Log was submitted; the Action Log contains the schedule of matters upon which the Board has asked for further action or information to be submitted. Matters on this log can only be deleted through resolution of the Board. (For the avoidance of doubt unless specified below all matters contained on the Board log will remain on the log until the Board resolves that the matter can be discharged).
Minute 01/26/08b & 03/26/05 – Manchester Arena Inquiry (MAI) Recommendations & Needs Analysis Register
The CEO informed the board that no further update had been received from NHS England on what the funding will be. It was agreed that this matter would remain on the Action Log to receive a further update at the next meeting.
Minute 03/26/07d
- Provider Capability Assessment outcome
- Quarterly Segmentation Outcome
The Strategy & Engagement Director informed the Board that this had now been superseded by this year’s return. On that basis it was agreed to discharge this action from the log.
Status: Discharged
Minute 05/26/07 (c) – Trust’s Five-Year Strategy – Update
The Board Strategy Session has been arranged for the afternoon of 25 November 2026. On this basis it was agreed to discharge this action from the log.
Status: Discharged
10/26/06 – To Confirm Actions taken at the Board Briefing Meeting held on 30 September 2026
06a – The People Strategy
To ratify the decision to approve the People Strategy for publication by 30 September 2026.
Resolved:
- That the Board of Directors ratified the decision to approve the People Strategy for publication by 30 September 2026.
06b – Board Capability Submission
Due to submission timescales, it was presented to the Board Briefing on 30 September 2026 for review prior to submission to NHS England on 2 October 2026.
Following review a number of updates were made prior to submission, with feedback from both Non-Executive & Executive Directors.
The report and Board Capability submission paper is submitted for ratification by the Board of Directors.
Resolved:
- That the report be received and noted.
- That the report and Board Capability submission paper was ratified by the Board of Directors.
10/26/07 – Board Assurance Framework (BAF)
The Board Assurance Framework was submitted for Board review by the Director of Nursing.
The Director of Nursing informed the Board that the BAF has been reviewed since the last report and all risks updated by the risk owners. The Director of Nursing drew to the Board attention the risk related to Hospital handover delays. These have deteriorated significantly since June 2026. Despite assurances from ICBs, acute trusts and NHS England, there has been no sustained improvement, increasing the risk of patient harm and prompting a proposed increase in the risk score from 20 to 25.
The Service Transformation & Patient Safety Director informed the Board that the situation has deteriorated, and we need to ensure we closely monitor this going forward. The Chairman pointed out that if we are as bad this year as last year then patient harm is undoubtedly happening. Mr Nat echoed this and explained this was reviewed in granular detail at the recent Finance & Performance Committee.
The Strategy & Engagement Director informed the Board that 2-3 years ago we undertook a deep dive into this, and we need to revisit this to ensure we are doing everything we can. Mr Khan agreed with this and said this is an accurate position to raise the level. We need to follow the process and do anything we can do. Mrs Banks confirmed a deep dive was also undertaken at the Quality Governance Committee regarding patient safety.
The Board agreed to increase the risk from 20 to 25.
The Medical Director explained that there is also increased pressure on our staff regarding the Offload Policy for delays and starting treatment in the back of ambulances. Mr Khan that is also captured in all the reports he has read.
Resolved:
- That the report be received and approved.
- That the Board of Directors approved the BAF.
- That the Board of Directors approved the increase from 20 to 25 for the risks related to handover delays.
10/26/08 – Chief Executive Officer Reports
08a – The CEO Report
A report of the CEO was submitted. The CEO highlighted the following salient matters from the report.
The CEO informed the Board that in June 2026, the Lord Mann review on antisemitism and other forms of racism in the NHS was published. As part of the review a total of 36 recommendations were made. Of the 36 recommendations one (Rec 5) relates to Board level oversight. We have had this in place for some time now.
We continue to progress the strategic workstreams. The CEO pointed out that at less than 4 weeks in, the Trust is already at 66% for its Flu Vaccination programme. The CEO was confident the Trust would achieve the 70% target. The CEO thanked the Flu vaccination team for the progress to date.
The CEO informed the Board of the very sad passing of one of our Senior Operations Manager Dan Swain at the weekend. He stated that Dan will be sadly missed. We are doing everything we can to support staff at the Hub. The Chairman echoed this and said Dan was a very well-known and popular member of staff and expressed his condolences to Dan’s family.
Resolved:
- That the report be received and noted.
08b – Performance Scorecards
- Executive Scorecard – September 2026
- Executive Scorecard ICS Sub Report – September 2026
The Executive Scorecards were submitted.
The CEO indicated that the content receives more detailed review by the Finance & Performance Committee.
Resolved:
- That the Executive Scorecards submitted be received and noted.
08c – NHS England Unauthorised Access Campaign: WMAS Progress Summary
A report of the Director of Finance was submitted.
The Director of Finance informed the Board that this is quite fast moving and the actions taken are at a point in time. WMAS has completed a substantial proportion of the immediate actions expected in response to Sir Jim Mackey’s correspondence and the NHS England campaign. Awareness, governance, Trust guidance development and leadership engagement are now well established
There are a number of actions completed and identified as ongoing to ensure WMAS conforms to the points in the NHSE letter and continues to adhere to Regulatory Requirements.
The Medical Director informed the Board that there is a lot of anxiety about what is appropriate and inappropriate. The National Caldicott Guarding’s are coming together to review this, and this is also on the agenda for the National Ambulance Services Medical Directors (NASMED) meeting. More guidance is expected in the next few weeks.
The CEO said the guidance will be helpful but if in doubt please do not access the record. We have undertaken some sample audits and there were no incidents of any staff unlawfully accessing records. If any such incidents are identified this will result in gross misconduct and dismissal.
The Chairman highlighted the good work undertaken by the Communications Team. The Director of Finance advised the Board that the Head of Risk & Governance produced this report and he has shared it with the national group who now have it on their agenda.
Resolved:
- That the report be received and noted.
10/26/09 – Report of the Director of People
09a – Gender Pay Gap Action Plan 2026/27
A report of the Director of People was submitted.
The Gender Pay Gap measures the difference in average pay between men and women in the NHS. The action plan puts measures in place to fix any unfair gaps in pay and remove barriers that stop women from reaching top-paying roles.
The action plan has identified areas for improvement based on data analysis and will be monitored for progress and assurance at DISAG and People Committee
Appendix 5 detailed the 2026 Gender Pay Gap report. Appendix 6 is the proposed Gender Pay Gap action plan (2026 / 2027) for approval.
The Gender Pay Gap action plan covers the period from 2026-2027.
Resolved:
- That the report be received and noted.
- That the Board of Directors approved the Gender Pay action plan for 2026 / 2027 for publication.
09b – Workforce Race Equality Standards – Action Plan 2026/27)
A report of the Director of People was submitted.
The NHS Workforce Race Equality Standard (WRES) was introduced in 2015 and is a set of specific measures that enables NHS organisations to show progress ensuring employees from black and minority backgrounds have equal access to career opportunities and receive fair treatment in the workplace.
The action plan has identified areas for improvement based on data analysis and will be monitored for progress and assurance at DISAG and People Committee
Appendix 1 detailed the 2026 WRES reporting metrics and appendix 7 is the Ethnicity Pay Gap comparison Report 2026. Both reports have informed Appendix 2 as the proposed WRES action plan (2026 / 2027) for approval.
Resolved:
- That the report be received and noted.
- That the Board of Directors approved the WRES action plan for 2026/2027 for publication.
09c – Workforce Disability Equality Standards Action Plan (2026/27)
A report of the Director of People was submitted.
The NHS Workforce Disability Equality Standard (WDES) came into force on 1 April 2019 and is a set of specific measures (metrics) that enables NHS organisations to compare the work lives of disabled staff to non-disabled staff. It checks if disabled staff feel valued, get the right equipment at work, or feel pressured to work when sick.
The action plan has identified areas for improvement based on data analysis and will be monitored for progress and assurance at DISAG and People Committee
Appendix 3 detailed the 2026 WDES reporting metrics. Appendix 4 is the proposed WDES action plan (2026 / 2027) for approval.
Resolved:
- That the report be received and noted.
- That the Board of Directors approved the WDES action plan for 2026/2027 for publication.
10/26/10 – Report of the Service Transformation & Patient Safety Director
10a – Fuller Inquiry Phase 2 – NHS Ambulance Sector Response and Actions Update and Board Assurance Statement
A report of the Service Transformation & Patient Safety Director was submitted.
The Service Transformation and Patient Safety Director informed the Board that Phase 1 of the Fuller Inquiry was released in November 2023, which investigated how an electrical engineer in an NHS Acute Trust was able to access deceased individuals and commit offences.
Phase 2 of the inquiry was released in July 2025 and explored national systems and practices in place across all sectors in the management of deceased persons. The report made 75 recommendations aimed at improving oversight and consistency. One chapter of this report specifically focuses on the ambulance sector.
This report outlines the inquiry recommendations made that are applicable to the trust and the current status of these and the Board Assurance template attached as an appendix is submitted for review and approval by the Board.
Resolved:
- That the report be received.
- That the Board of Directors approved the Board Assurance Statement.
10b – Thirlwell Inquiry Recommendations
A report of the Service Transformation & Patient Safety Director was submitted.
The Service Transformation & Patient Safety Director explained that the paper submitted today provides members with an initial needs analysis following publication of the Thirlwall Inquiry Report, identifying the recommendations and wider learning potentially applicable to the Trust and the areas in which further assurance, evidence, policy review or improvement activity may be required.
The paper seeks agreement to undertake a structured Trust-wide assessment against the applicable recommendations and learning arising from the Inquiry, with subsequent reporting through the Trust’s established governance arrangements.
Although a number of the Inquiry’s recommendations are specifically directed towards neonatal services, hospital trusts, NHS England, the Department of Health and Social Care and national organisations, the report contains important wider learning for healthcare organisations concerning patient safety, safeguarding, escalation of concerns, organisational culture, leadership accountability, Freedom to Speak Up, duty of candour and the use of data to identify emerging risks.
The Service Transformation & Patient Safety Director confirmed there were no risks or concerns. Mr Nat acknowledged the detailed analysis.
Resolved:
- That the report be received and noted.
- That the Board of Directors agreed to undertake a structured Trust-wide assessment against the applicable recommendations and learning arising from the Inquiry, with subsequent reporting to Board through the Trust’s established governance committees.
10/26/11 – Reports of the Director of Finance
11a – Finance Update
A report of the Director of Finance was submitted.
The Director of Finance gave an update and the following was noted.
- At month 6 the Trust reported a £1.5m surplus compared to a planned deficit of £300k. We are still planning for breakeven.
- CIPs are overperforming to target with work ongoing to increase the recurrent element which will reduce the pressure on future years.
- Better Payments Practice Code results continue to be above the required 95% target overall.
- Capital resource for 2026/27 is planned with the overall programme totalling £47m. Work is ongoing to ensure the programmes of work are progressing, which is closely monitored via the Financial Investment Group (FIG). Risks to delivery are timescales relating to some suppliers lead times.
- Non pay restrictions will continue to be in place to contribute to delivery of the financial target of breakeven. There is continued scrutiny being applied to all spend, both essential and discretionary across non-core areas as well as the vacancies being held.
- At the half-year point the underspend in pay is due to the vacancies held.
- NHS England has sent messages to organisations asking them to go better than planned. The Director of Finance confirmed that the Trust is heading for breakeven. Anything beyond that would be very difficult.
The Director of Finance informed the Board that the key risks are as follows.
- The impact of hospital handover delays on lost hours. We are now assuming this to be 380,000 hours. Page 5 of the run rate shows an increase in income and expenditure due to the hours lost.
- Fuel costs are an increasing risk. The basis cost is rising every month. We are managing this with the suppliers but there is little we can do about this.
- Capital delivery is dependent on suppliers.
Mr Nat pointed out that there are deep dives in various committees. The one big stand out relates to CIPs. Every year we have identified the CIP. This year’s over performance on the CIP when we are facing issues like the fuel increase. The Director of Finance explained that the fuel increase does not have an impact on the CIP, we just have to manage this. We have good process in place for CIPs.
The Chairman asked in relation to handover delays that it looked like this will be a similar position for the Trust as last year. Are we assuming the level of income to match this. The Director of Finance confirmed we were. The CEO pointed out that the Workforce Plan also matches that. The Director of Finance explained that this is how we will develop the forecast outturn.
Resolved:
- That the Board of Directors noted the reported results for Month 6 of the 2026/27 financial year and the additional information contained in the Finance Pack to aid understanding.
- That the Board of Directors noted the current risks, specifically increased run rate, spend reductions, handover activity including overtime requirements and fuel pricing.
10/26/12 – Combined Clinical Directors Quality Reports
The combined Clinical Directors Report was submitted.
The Service Transformation & Patient Safety Director informed the Board that the report highlights specific areas that the Board need to be sighted on. Patient handover delays remain the highest risk for the Trust at a score of 25. The delays in responding to patients that is caused by the above risks result in patient harm and long patient waiting times causing harm, that does unfortunately include deaths, increasing workloads to the Trusts Operational, Patient Safety and corporate services.
The Call Before You Convey Programme Board is progressing well. Electronic controlled drug implementation is scheduled for Q4 2026/27Electronic patient record (EPR) task and finish group established, with the aim to radically simplify. This is informed by surveys of our operational staff where there was significant support to simplify the EPR. Roll out confirmed early November 2026.
Resolved:
- That the Combined Clinical Directors Quality Report submitted be received and noted.
- That it is acknowledged that there remains the continued risks of patient harm being caused as the result of delayed responses, long handover delays and stacking calls in EOC.
10/26/13 – Service Delivery Report
A report of the Chief Operating Officer was submitted highlighting various matters contained within the report.
The Chief Operating Officer gave an update as follows:
- Category 2 mean response time was 24 minutes 29 seconds for September, with ongoing pressure linked to demand and handover delays.
- Call handling performance remained strong, with an average call answer time of 3 seconds and a 95th percentile wait of 23 seconds.
- YTD Category 2 remains strong at 21:19 mins at the end of September and the half year position. The end year position trajectory at 24min and 30 seconds.
- Demand is higher than the previous year.
- September recorded 32,810 lost hours due to handover delays.
- Only 28.5% of handovers were completed within 15 minutes.
- Overtime is open at present to try to mitigate the risks to patients.
Mr Nat said given the number of calls taken call answering performance was very impressive. The CEO informed the Board that we are recruiting staff to vacant posts. The Chairman said when we stopped providing the 111 Service, we had more call handlers than established posts. The CEO agreed that was the case 3 years ago but now we are back to the funded establishment level. We have filled all vacancies, but some are still in training. For the next report we will add in a table that shows 2-minute delays or all ambulance services.
Resolved
- That the report be received and noted.
10/26/14 – Board Committee Meeting Minutes & Chairs Reports
14a – Audit Committee
The Chairs Report of the Audit Committee meeting held on 13 October 2026 was submitted along with the minutes of the meeting held on 21 July 2026.
In the absence of Julie Jasper Audit Committee Chair, Mr Nat highlighted the salient points from the meetings as follows.
- The Audit Certificate has still not been issued nationally by the National Audit Office.
- We invoked a discussion with the External Auditors on the Trust’s Deprecation Policy and if this is reasonable. A more detailed deep dive will be undertaken at the F&P Committee.
- Business Continuity review was completed with significant assurance. Only minor opportunities for improvement are noted.
- PTS review completed with partial assurance with some improvements and suggested recommendations.
- KPMG ‘thought leadership’ updates to be forwarded to EMB and Committees for information.
- Had a session on local counter fraud as well.
- The BAF was discussed, however it was noted that this was the July version. This will be updated before the next Board meeting on 28 October.
Items for escalation to Board as follows:
- BAF and risk appetite to be discussed in detail at the November Board development session.
- Access to patient records. The Trust has sent out some strong messaging showing a good transparent approach to this item.
- A reminder for everyone to attend the fraud awareness sessions.
Resolved:
- That the Chairs Report of the meeting held on 13 October 2026 be received and noted.
- That the minutes of the meeting held on 21 July 2026 be received and noted.
14b – People Committee
The Chairs Report of the People Committee meetings held on 10 August, and 5 October 2026 was submitted along with the minutes of the meetings held on 1 June and 10 August 2026.
In the absence of Mr Fessal Mrs Banks highlighted the salient points from the meetings as follows.
- Minutes of 10 August were approved.
- No new risks were identified.
- We need to monitor the training capacity.
- The Committee highlighted the importance of staff stories to our Board. We have not received one for a while now.
- Workforce indicators remained stable overall, with low turnover.
- Some progress in BAME recruitment.
- Positive feedback was also received on the day-in-the-life activity and hub visits, which are strengthening Board visibility and enabling useful triangulation with staff experience. The Committee noted the value of continuing this work while encouraging wider participation across the organisation.
- It was agreed that the Sexual Safety & Wellbeing Group would remain as a stand-alone group and report into the People Committee.
- Launch of staff survey with the initial response rate very good. The People Director informed the Board that the Trust is currently the highest performer of all providers apart from the ICB.
Resolved:
- That the Chairs Report of the meetings held on 10 August, and 5 October 2026 be received and noted.
- That the minutes of the meetings held on 1 June, and 10 August 2026 be received and noted.
14c – Finance & Performance Committee
The Chairs Report of the Finance & Performance Committee meeting held on 15 September 2026 was submitted along with the minutes of the meeting held on 20 July 2026.
Mr Khan as Chair of the F&P committee highlighted the salient points from the meeting as follows.
- The COO and Director of Finance provided updates to the committee.
- Financially we are in a very strong position, however expenditure pressures, fuel-price volatility and the level of lost hours continue to require close scrutiny.
- Concern was raised about commercial services and 11 contracted KPI failures which were due to vacancies and vehicles being off road particularly in Cheshire, Coventry & Warwickshire and Birmingham. Interventions are being put in place for these.
- We need to look at these non-core services and agree our strategic approach.
- Hospital handover delays is a continuing concern which cannot be resolved by the Trust alone. This is why it has been escalated to the Board to see what else could be done.
Resolved:
- That the Chairs Report of the meeting held on 15 September 2026 be received and noted.
- That the minutes of the meeting held on 20 July 2026 be received and noted.
14d – Quality Governance Committee (QGC)
The Chairs Report of the QGC meeting held on 23 September 2026 was submitted along with the minutes of the meeting held on 28 July 2026 were submitted.
Suzanne Banks, Chair of the QGC, highlighted the following salient points.
- No apologies were received.
- Patient handover delays and lack of 45-minute handover at hospitals continue with hours lost, resulting in patient harm, and long patient waits in the community.
- Concerns raised by Medical Director around the lack of an agreed regionwide escalation procedure for Paramedics to raise concerns over change of patient condition in NEWS2 score.
- Treatment of patients by ED staff in rear of ambulance, or patients being treated in ED and put back on ambulance e.g. was still seen as a risk.
- Pre alerts not being actioned in some Hospitals. Also, concerns re lack of response from Acute Trusts when patient safety issues have been raised.
- Corporate Team resources. We noted the reduction of resources in corporate teams.
- Report regarding the impact of staff shortages, existing vacancies around PTS. Patient Safety impact on gap in service provision and delayed / failed discharges rescheduled for November meeting following review at EMB.
- Scheduled deep dives for future meetings 2026/27 include Safeguarding and a 6-month review following original deep dive on Ambulance Handover delays.
- There was good discussion and challenge.
Issues raised:
- Patient Experience Risk Assessment discussed, and feedback given regarding the scoring.
- Lack of Patient Experience / Engagement activity continues – FFT numbers low and reported halting of the Patient Forum, both due to reported capacity issues within the team.
- Good assurance provided with Mental Health provision.
- IG update on Investigating Unlawful and Inappropriate Data / Record Access. National guidance discussed and work underway to implement the process from 1st October. Update to be provided at next meeting.
Resolved:
- That the Chairs Report of the meeting held on 23 September 2026 be received and noted.
- That the minutes of the meeting held on 28 July 2026 be received and noted.
10/26/15 – Board Schedule of Business
The schedule was submitted.
The chairman apologised for some of the changes in dates. The Chairman confirmed that he would also review the dates of meetings around school half term.
Resolved
- That the Board Schedule of Business be received and noted.
10/26/16 – Any Other Business
There was no other business.
10/26/17 – The Date of the Next Meeting
Wednesday 25 November 2026
There being no other business for this meeting the Chairman brought proceedings to a close and thanked members for their attendance.
10/26/18 – Risks Arising from the Meeting
The key risk highlighted was the increase in the risk related to hospital handover delays from 20 to 25.